Sensitivity of HIV type 1 primary isolates to human Anti-CD40 antibody-mediated suppression is related to coreceptor use

被引:3
作者
Abayneh, Sisay A. [1 ]
Ellmark, Peter [2 ]
Karlsson, Ulf [3 ]
Andersson, Henrik [2 ]
Borrebaeck, Carl A. K. [2 ]
Karlsson, Ingrid [1 ]
Fenyo, Eva Maria [1 ]
机构
[1] Lund Univ, Dept Lab Med, Div Med Microbiol, SE-22362 Lund, Sweden
[2] Lund Univ, Dept Immunotechnol, SE-22362 Lund, Sweden
[3] Lund Univ, Dept Expt Med Sci, SE-22362 Lund, Sweden
关键词
D O I
10.1089/aid.2007.0216
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The effect of CD40 ligation on infection by HIV-1 primary isolates with different R5 phenotypes was evaluated with a novel set of anti-CD40 monoclonal antibodies originating from a human phage display library. Five human monoclonal anti-CD40 antibodies of IgG1 subtype characterized by the ability to activate B cells via CD40 were tested for induction of the CC-chemokines RANTES and MIP-1 alpha and inhibition of HIV-1 replication in primary monocyte-derived macrophages (MDM). All activating anti-CD40 antibodies were able to induce CC-chemokines in MDM. We chose the most potent antibody, clone B44, for further experiments. This antibody had a suppressive effect on HIV-1 isolates of the R5 phenotype with limited use of CCR5/CXCR4 chimeric receptors. In comparison, HIV-1 isolates with broader use of CCR5/CXCR4 chimeric receptors or with CXCR4 use were less sensitive to anti-CD40-induced suppression. The results indicate that HIV-1 replication is inhibited by human anti-CD40 monoclonal antibodies through the mechanism of CC-chemokine induction. This effect is thus restricted to HIV-1 isolates sensitive to inhibition by CC-chemokines.
引用
收藏
页码:447 / 452
页数:6
相关论文
共 33 条
[1]   Cytokine, chemokine, and costimulatory molecule modulation to enhance efficacy of HIV vaccines [J].
Ahlers, JD ;
Belyakov, IM ;
Berzofsky, JA .
CURRENT MOLECULAR MEDICINE, 2003, 3 (03) :285-301
[2]   Molecular mapping of epitopes for interaction of HIV-1 as well as natural ligands with the chemokine receptors, CCR5 and CXCR4 [J].
Antonsson, L ;
Boketoft, A ;
Garzino-Demo, A ;
Olde, B ;
Owman, C .
AIDS, 2003, 17 (18) :2571-2579
[3]   CD40-activated macrophages become highly susceptible to X4 strains of human immunodeficiency virus type 1 [J].
Bakri, Y ;
Mannioui, A ;
Ylisastigui, L ;
Sanchez, F ;
Gluckman, JC ;
Benjouad, A .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2002, 18 (02) :103-113
[4]   Increased CD4 and CCR5 expression and human immunodeficiency virus type 1 entry in CD40 ligand-stimulated macrophages [J].
Bergamini, A ;
Bolacchi, F ;
Pesce, CD ;
Carbone, M ;
Cepparulo, M ;
Demin, F ;
Rocchi, G .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (11) :1567-1577
[5]   CD40 ligation counteracts Fas-induced apoptosis of human dendritic cells [J].
Bjorck, P ;
Banchereau, J ;
FloresRomo, L .
INTERNATIONAL IMMUNOLOGY, 1997, 9 (03) :365-372
[6]   C4b-binding protein (C4BP) activates B cells through the CD40 receptor [J].
Brodeur, SR ;
Angelini, F ;
Bacharier, LB ;
Blom, AM ;
Mizoguchi, E ;
Fujiwara, H ;
Plebani, A ;
Notarangelo, LD ;
Dahlback, B ;
Tsitsikov, E ;
Geha, RS .
IMMUNITY, 2003, 18 (06) :837-848
[7]   Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation [J].
Cella, M ;
Scheidegger, D ;
PalmerLehmann, K ;
Lane, P ;
Lanzavecchia, A ;
Alber, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :747-752
[8]  
Chougnet C, 1999, J IMMUNOL, V163, P1666
[9]   What is the real role of CD40 in cancer immunotherapy? [J].
Costello, RT ;
Gastaut, JA ;
Olive, D .
IMMUNOLOGY TODAY, 1999, 20 (11) :488-493
[10]   Regulation of human immunodeficiency virus type 1 infection, β-chemokine production, and CCR5 expression in CD40L-stimulated macrophages:: Immune control of viral entry [J].
Cotter, RL ;
Zheng, JL ;
Che, M ;
Niemann, D ;
Liu, Y ;
He, J ;
Thomas, E ;
Gendelman, HE .
JOURNAL OF VIROLOGY, 2001, 75 (09) :4308-4320